| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Neurocircuitry of Addiction | Neuropsychopharmacology | 2010 | 4,338 |
| 2 | The Reward Circuit: Linking Primate Anatomy and Human Imaging | Neuropsychopharmacology | 2010 | 3,053 |
| 3 | DNA Methylation and Its Basic Function | Neuropsychopharmacology | 2013 | 3,049 |
| 4 | Drug Addiction, Dysregulation of Reward, and Allostasis | Neuropsychopharmacology | 2001 | 2,461 |
| 5 | The Corticosteroid Receptor Hypothesis of Depression | Neuropsychopharmacology | 2000 | 1,889 |
| 6 | The Neurocircuitry of Fear, Stress, and Anxiety Disorders | Neuropsychopharmacology | 2010 | 1,735 |
| 7 | Synaptic Plasticity: Multiple Forms, Functions, and Mechanisms | Neuropsychopharmacology | 2008 | 1,565 |
| 8 | Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms | Neuropsychopharmacology | 2008 | 1,514 |
| 9 | Human and Rodent Homologies in Action Control: Corticostriatal Determinants of Goal-Directed and Habitual Action | Neuropsychopharmacology | 2010 | 1,498 |
| 10 | Neural Mechanisms of Extinction Learning and Retrieval | Neuropsychopharmacology | 2008 | 1,425 |
| 11 | Allostasis and Allostatic Load Implications for Neuropsychopharmacology | Neuropsychopharmacology | 2000 | 1,363 |
| 12 | Neurocircuitry of Mood Disorders | Neuropsychopharmacology | 2010 | 1,362 |
| 13 | Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety | Neuropsychopharmacology | 2010 | 1,236 |
| 14 | The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia | Neuropsychopharmacology | 1999 | 1,170 |
| 15 | Normal Development of Brain Circuits | Neuropsychopharmacology | 2010 | 1,084 |
| 16 | Discovering Endophenotypes for Major Depression | Neuropsychopharmacology | 2004 | 1,068 |
| 17 | Dissociable Roles of Prelimbic and Infralimbic Cortices, Ventral Hippocampus, and Basolateral Amygdala in the Expression and Extinction of Conditioned Fear | Neuropsychopharmacology | 2011 | 1,033 |
| 18 | Stress Effects on Neuronal Structure: Hippocampus, Amygdala, and Prefrontal Cortex | Neuropsychopharmacology | 2016 | 1,029 |
| 19 | Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder | Neuropsychopharmacology | 2002 | 987 |
| 20 | GABAergic Interneurons Implications for Understanding Schizophrenia and Bipolar Disorder | Neuropsychopharmacology | 2001 | 984 |
| 21 | Dissociable Deficits in the Decision-Making Cognition of Chronic Amphetamine Abusers, Opiate Abusers, Patients with Focal Damage to Prefrontal Cortex, and Tryptophan-Depleted Normal Volunteers Evidence for Monoaminergic Mechanisms | Neuropsychopharmacology | 1999 | 960 |
| 22 | Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine | Neuropsychopharmacology | 1996 | 941 |
| 23 | The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis | Neuropsychopharmacology | 2004 | 913 |
| 24 | Drug Addiction as a Pathology of Staged Neuroplasticity | Neuropsychopharmacology | 2008 | 909 |
| 25 | Deep Brain Stimulation to Reward Circuitry Alleviates Anhedonia in Refractory Major Depression | Neuropsychopharmacology | 2008 | 906 |
| 26 | Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology | Neuropsychopharmacology | 2003 | 866 |
| 27 | From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment | Neuropsychopharmacology | 2012 | 859 |
| 28 | The current status of the dopamine hypothesis of schizophrenia | Neuropsychopharmacology | 1988 | 857 |
| 29 | Cortico-Basal Ganglia Reward Network: Microcircuitry | Neuropsychopharmacology | 2010 | 838 |
| 30 | Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior | Neuropsychopharmacology | 2012 | 811 |
| 31 | The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis | Neuropsychopharmacology | 2011 | 798 |
| 32 | Behavioral Alterations in Rats Prenatally Exposed to Valproic Acid: Animal Model of Autism | Neuropsychopharmacology | 2005 | 783 |
| 33 | Frontocingulate Dysfunction in Depression: Toward Biomarkers of Treatment Response | Neuropsychopharmacology | 2011 | 781 |
| 34 | Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia | Neuropsychopharmacology | 1995 | 763 |
| 35 | Three-Year Outcomes in Deep Brain Stimulation for Highly Resistant Obsessive–Compulsive Disorder | Neuropsychopharmacology | 2006 | 754 |
| 36 | Cell Proliferation in Adult Hippocampus is Decreased by Inescapable Stress: Reversal by Fluoxetine Treatment | Neuropsychopharmacology | 2003 | 721 |
| 37 | The Catechol-O-Methyltransferase Polymorphism: Relations to the Tonic–Phasic Dopamine Hypothesis and Neuropsychiatric Phenotypes | Neuropsychopharmacology | 2004 | 711 |
| 38 | H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs | Neuropsychopharmacology | 2003 | 708 |
| 39 | Olanzapine versus Placebo and Haloperidol | Neuropsychopharmacology | 1996 | 704 |
| 40 | Neurobehavioral Effects of Interferon-α in Cancer Patients Phenomenology and Paroxetine Responsiveness of Symptom Dimensions | Neuropsychopharmacology | 2002 | 688 |
| 41 | Neurobiological Similarities in Depression and Drug Dependence: A Self-Medication Hypothesis | Neuropsychopharmacology | 1998 | 673 |
| 42 | Postpubertal Emergence of Hyperresponsiveness to Stress and to Amphetamine after Neonatal Excitotoxic Hippocampal Damage: A Potential Animal Model of Schizophrenia | Neuropsychopharmacology | 1993 | 672 |
| 43 | Neuroanatomical and Neurochemical Substrates of Timing | Neuropsychopharmacology | 2011 | 672 |
| 44 | Adult Attachment Predicts Maternal Brain and Oxytocin Response to Infant Cues | Neuropsychopharmacology | 2009 | 655 |
| 45 | Cytokine Production and Treatment Response in Major Depressive Disorder | Neuropsychopharmacology | 2000 | 653 |
| 46 | Interaction between BDNF and Serotonin: Role in Mood Disorders | Neuropsychopharmacology | 2008 | 651 |
| 47 | Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence | Neuropsychopharmacology | 1998 | 650 |
| 48 | Oxytocin Infusion Reduces Repetitive Behaviors in Adults with Autistic and Asperger's Disorders | Neuropsychopharmacology | 2003 | 650 |
| 49 | Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo, Human Serotonin Receptor Subtypes, and Other Neuronal Receptors | Neuropsychopharmacology | 2001 | 646 |
| 50 | Inhibitors of Class 1 Histone Deacetylases Reverse Contextual Memory Deficits in a Mouse Model of Alzheimer's Disease | Neuropsychopharmacology | 2010 | 644 |
